>
Switch to:

Instil Bio EV-to-EBIT

: -30.25 (As of Today)
View and export this data going back to 2021. Start your Free Trial

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Instil Bio's Enterprise Value is $1,778.03 Mil. Instil Bio's EBIT for the trailing twelve months (TTM) ended in Jun. 2021 was $-58.78 Mil. Therefore, Instil Bio's EV-to-EBIT for today is -30.25.

The historical rank and industry rank for Instil Bio's EV-to-EBIT or its related term are showing as below:

NAS:TIL' s EV-to-EBIT Range Over the Past 10 Years
Min: -30.37   Med: -1.64   Max: 2.61
Current: -30.07

-30.37
2.61

During the past 2 years, the highest EV-to-EBIT of Instil Bio was 2.61. The lowest was -30.37. And the median was -1.64.

NAS:TIL's EV-to-EBIT is ranked lower than
99.99% of the 37 Companies
in the Biotechnology industry.

( Industry Median: 21.16 vs. NAS:TIL: -30.07 )

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Instil Bio's Enterprise Value for the quarter that ended in Jun. 2021 was $1,920.59 Mil. Instil Bio's EBIT for the trailing twelve months (TTM) ended in Jun. 2021 was $-58.78 Mil. Instil Bio's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jun. 2021 was -3.06%.


Instil Bio EV-to-EBIT Historical Data

The historical data trend for Instil Bio's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Instil Bio Annual Data
Trend Dec19 Dec20
EV-to-EBIT
- -

Instil Bio Quarterly Data
Dec19 Mar20 Jun20 Dec20 Mar21 Jun21
EV-to-EBIT Premium Member Only - - - -93.56 -32.67

Competitive Comparison

For the Biotechnology subindustry, Instil Bio's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

   

Instil Bio EV-to-EBIT Distribution

For the Biotechnology industry and Healthcare sector, Instil Bio's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Instil Bio's EV-to-EBIT falls into.



Instil Bio EV-to-EBIT Calculation

Instil Bio's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=1778.029/-58.784
=-30.25

Instil Bio's current Enterprise Value is $1,778.03 Mil.
Instil Bio's EBIT for the trailing twelve months (TTM) ended in Jun. 2021 adds up the quarterly data reported by the company within the most recent 12 months, which was $-58.78 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Instil Bio  (NAS:TIL) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Instil Bio's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jun. 2021 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Jun. 2021 ) =EBIT / Enterprise Value (Q: Jun. 2021 )
=-58.784/1920.58976
=-3.06 %

Instil Bio's Enterprise Value for the quarter that ended in Jun. 2021 was $1,920.59 Mil.
Instil Bio's EBIT for the trailing twelve months (TTM) ended in Jun. 2021 adds up the quarterly data reported by the company within the most recent 12 months, which was $-58.78 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Instil Bio EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Instil Bio's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Instil Bio Business Description

Instil Bio logo
Industry
Healthcare » Biotechnology NAICS : 325412 SIC : 2834
Comparable Companies
Traded in Other Exchanges
N/A
Address
3963 Maple Avenue, Suite 350, Dallas, TX, USA, 75219
Instil Bio Inc is a clinical-stage cell therapy company. It is developing tumor infiltrating lymphocytes for the treatment of cancer.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)